Sherry G Clendenon

Title: Sherry G. Clendenon: Innovator in Cystic Kidney Disease Research

Introduction

Sherry G. Clendenon is a notable inventor based in Indianapolis, IN (US). She has made significant contributions to the field of medical research, particularly in understanding and treating cystic kidney diseases. Her innovative work has led to the development of a patent that addresses critical aspects of this health issue.

Latest Patents

Clendenon's patent, titled "Targeting cGMP-related phosphodiesterases to reduce cyst formation in cystic kidney disease, and related materials and methods," focuses on the identification of cGMP-specific phosphodiesterase upregulation in cystic kidney diseases. The patent describes the use of cGMP-specific phosphodiesterase inhibitors for preventing the progression and/or treatment of cystic kidney diseases. Additionally, it outlines methods for diagnosing cystic kidney disease and provides medicaments aimed at treating this condition. Clendenon holds 1 patent in this area.

Career Highlights

Throughout her career, Clendenon has worked with prestigious institutions, including Indiana University and the United States Government as represented by the Department of Veterans Affairs. Her research has been instrumental in advancing the understanding of cystic kidney diseases and developing potential treatments.

Collaborations

Clendenon has collaborated with esteemed colleagues such as Robert Bacallao and James A. Glazier. These partnerships have enhanced her research efforts and contributed to the success of her innovative projects.

Conclusion

Sherry G. Clendenon is a pioneering inventor whose work in cystic kidney disease research has the potential to improve patient outcomes significantly. Her contributions to medical science exemplify the impact of innovation in addressing complex health challenges.